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ABSTRACT
Influence of Lipophilicity on the Accumulation and
Distribution of Halogenated Phenols and a Pyridinol
as Metabolites of Pesticides in the Rat
by
Assed A. Attumi, Master of Science
Utah State University, 1981
Ma jor Professor: Dr. Joseph C. Street
Department: Grad uate Program in Toxicology
Exposure to halogenated phenols and pyridinols is of increasing
concern because of their wide use and distribution.

This research

was initiated to determine the distribution, accumulation, and
depletion of a group of halogenated phenols and a pyridinol in
selected tissues of ma le wean ling rats at different time intervals
following a single oral dose of 0.33 or 1.66 m moles per kg body
weight .

The halogenated pheno ls and pyridinol were distributed

differently in every tissue sampled following their administration,
even though the amount administered was the same in each case.
concentrations in tissue were found in the order:
phenol

>

4-bromo-2,5-dichlorophenol

>

The

2,4,5-trichloro-

4-iodo-2,5-dichlorophenol

>

3,5,6-trichloro-2-pyridonol in kidney and fat, whereas the series
3,5,6-trichloro-2-pyridinol
2,5-dichlorophenol

>

>

4-iodo-2,5-dichlorophenol

>

4-bromo-

3,5,6-trichlorophenol occurred in liver.

No

ix

structurally significant series

~1as

observed for their concentrations

in blood.
All halogenated phenols and pyridinol concentrations in tissues
declined rapidly with time but not always in an apparently log linear
fashion.

Rates were greatest for clearance from blood.

The highest

concentration of halogenated phenols was in kidney among the tissues
studied, whereas the highest concentration of halogenated pyridinol
was in 1i ver.
Relationships were found between the relative lipophilicity,
as indicated by the chromatographic Rm value, and the concentratio ns of these compounds in tissues.
liponhilicity) was generallv very

w~ll

The Rm (i.e., relative
correlated with the log

concentration of compounds in tissues observed 24 h after dosing.
The correlation coefficients ranged between .517 and .995 among
tissues.

Correlations were positive between the Rm values and 24 h

concentrations in adipose tissue, and kidney, but negative for the
relationship between the Rm and 24 h concentrations in blood and
1 iver .

(91 pages)

INTRODUCTION
The lower halogenated phenols have been in use as fungicides,
herbicides, insecticides and precursors in the synthesis of other
pesticides since the early 1930 's.

Production of these chlorinated

phenols has at times been the cause of problems with regard to
industrial hygiene but has otherwise not created notable environmental problems.

Many organophosphate and organochlorine insecti-

cides are well known man-made environmental pollutants that have
been used for several decades in agriculture and industry .

It is

well known that organochlorine pesticides are soluble in fat and
some are highly persistent in the tissue of animals; halogenated
phenols may act similarly.

On the other hand, these halogenophenols

are major metabolites of several organophosphorus and a few organochlorine insecticides which are, themselves, readily biodegradable.
Most literature reports indicated that the halogenated phenolic
metabolites of these insecticides were found in urine, but only
recently have these metabolites also been found i n the animal
tissues .

As of this date, there have been few reports of studies

with the lower halogenated phenols in animals and data on accumulation and depletion rates of halogenated phenols as residues in
animal tissues are lacking.

A similar lack exists for information

about those halogenated pyridinols used in pesticide manufacture.
There is a general relationship between lipophilicity and many
types of biological activity for related structures among classes

of foreign compounds and it has been found that lipophilicity is
one of the most important factors in controlling the interaction
of chemicals with biological systems.

However, no work was found

in the literature regarding the relationship between the structure
of the halogenated phenols and pyridinols, their lipophilicity and
their concentration in animal tissues .

The purpose of this research

was to identify the importance of relative lipophilicity as a characteristic influencing the biological distribution of these compounds.
This study was planned to determine if rats do indeed accumulate
halogenophenols and halogenopyridinols and, if so, in which major
tissues.

Knowledge of the tissue distribution of halogenated

phenols and pyridinols accumulated by rats will be of value in
~lucidating

sublethal physiological responses of these animals to

low level exposures to agents yielding these compounds upon
metabolism.
Two objectives in this study purused structural relationships
among selected halogenated phenols and a pyridinol in comparison
to:

a) their distribution in blood, kidney, liver, and fat (adi-

pose tissue); and b) their persistence in and depletion from these
tissues with time.

REVIE\4 OF LITERATURE
Historical Background and
Use of Ha 1a gena ted Pheno 1s
The first halogenated phenol sy nthesized was pentachlorophenol
(Erdma nn 1B41; Laurent 1841).

However, neither of those chemists

determined the correct structure of the compound.

Several dif -

ferent methods for synthesis were later tried until the preparation of pentachlorophenol by direct chlorination of phenol in
the presence of a catalyst was reported by Merz and Weith (1872).
Modern production of pentachlorophenol or lower chlorophenols may
be performed in two ways (Melnikov 1971; Zollner et al. 1978):
by direct chlorination of phenol, ch lorophenols, or polychlorophenols with chlorine in t he presence of catalysts at an elevated
temperature or by alkaline hydrolysis of ch lorobenzenes in mixtures of different solvents.

Both methods may give rise to the

formation of contaminants such as chlor inated dibenzodioxins,
dibenzofurans and 2-phenoxyphenols (predioxins) (Ahlberg 1977) .
In 1936, production of halogenated phenols was started on a
commercial scale, particularly of pentachlorophenol which was used as
a preservative for wood and wood products and an agent to control
mold, mildew and termites on wood (Carswell and flason 1938).
4-Bromo-2,5-dichlorophenol has also found use as a wood preservative (Imamura et al. 1978; Tilemans 1977 ) .

Pentachlorophenol has

been used as a herbicide in pineapple and sugarcane fields (Beve nue
and Beckman 1967).

For many years, 2,4,5 - trichlorophe nol has been
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used effectively as a fun gicide in many major industri es, including
textile, leather, and glue manufacturing processes.

More recently,

pentachlorophenol, 4-bromo-2,5-dichlorophenol, and 4-iodo-2,5dichlorophenol have found use as molluscicides (Roushdy et al.
1974; Yamamoto and Kasuga 1976, 1977; Imamura et al . 1977).

More

than that, halogenated phenols and halogenated pyridinols have found
use as intermediates in the production of several important pesticides developed during the last two decades, such as Ronnel, leptophos, iodophos, and chlorpyrifos (McCollister et al. 1959).

The

annual use of pentachlorophenol in the U.S.A. is probably more than
20,000 tons and was estimated to be more than 24,000 tons in 1974
(Arsenault 1976).
Toxicity of Halogenated Phenols
Modern data on the toxicity of lower halogenated phenols seems
to be absent although many studies have been conducted on the penta chlorophenol and tetrachlorophenols.

Early studies on their toxi-

ci ty were performed due to an interest in them as antiseptic
compounds (Bechhold and Ehrlich 1906) .

The l iterature up to 1949

has been excellently reviewed by Von Oettingen (1949).

The con-

clusions that can be drawn from the ear lier work reviewed by Von
Oettingen (1949) were confirmed in a study by Farquharson et al.
(19 58).

The authors concluded that with i ncreasing chlorination

there is an increase in toxicity in which the convulsant action of
phenol is replaced by the signs characteristic of poisoning by
dinitrophenol, a well-known uncoupler of oxidative phosphorylation.

Based on determinations of the dissociation constants for the
chlorinated phenols, they suggested that the higher chlorinated
phenols interfere with oxidative phosphorylation.

The convulsant

action of the lower chlorinated phenols, on the other hand, was
assumed to be associated with the undissociated molecule.
Although 2,4,5-trichlorophenol has been used in industry for
many years, little toxicity data have been reported in the literature.

Deichman and Mergard (1948) reported an acute oral LD50 in

rats in the range of 0.62-0.825 g per kilogram body weight.

Anderson

et al. {1949) fed groups of cattle dosages of 0.8, 2.4, and 7.2 g
per 100 lbs animal weight per day of zinc 2,4,5-trichlorophenute
and 2,4,5-trichlorophenyl acetate in the diet for 78 and 154 days.
They observed no adverse effects at any of the levels fed .

For a

98-day feeding trial using rats and a dose range of .03-1.0 g/kg/day
of 2,4,5-trichlorophenol.

McCollister et al. {1961) found that

rats maintained at the higher dose level sho•1ed diuria, but only
mild reversible pathological changes were seen in the liver and
kidneys.

Those fed lower dose levels showed no evidence of adverse

effects.

Repeated oral feeding (20 doses in 28 days) by intubation

to rabbits produced very slight pathological changes in liver and
kidneys in those animals receiving 0.5 g/kg doses of 2,4,5trichlorophenol.

In a similar study, there was no evidence of

adverse effect in rats at 0.3 and 1.0 g/kg.

The only significant

effect attributable to 2,4,5-trichlorophenol was a slight increase
in average weight of the kidneys.
found upon microscopic examination.

No pathological changes were
2,4,5-trichlorophenol at a

dose rate as high as 400 mg/kg administered orally for 14 days in
rats decreased microsomal NADPH-cytochrome C reductase activity and
cytochrome P450 content (Carlson 1978).

UDP-glucuronyltransferase

was slightly inhibited in vit ro and was not altered in vivo.

The

compound was not hepatotoxic as assessed by measurement of hepatic
glucose-6-phosphatase and serum sorbitol dehydrogenase .
Toxicity data for 4-bromo-2,5-dichlorophenol, 4-iodo-2,5dichlorophenol, and 3,5,6-trichloro-2-pyridinol are complete ly
absent in reported literature.
Organophosphate Insecticides with
Halogenated Phenolic Metabolites
Halogenated phenols and related compounds such as halopyridinols are mammalian metabolites of many insecticides, including
Leptophos ( phosve l) [Q- ( 4-bromo 2, 5-di chl orophenyl ) -Q-methyl phenyl
phosphonothioate], chlorpyrifos (Dursban) [Q,Q-diethyl Q-(3,5,6
tri chl oro- 2-pyri dyl) phosphorothi oate], and Ronnel [.Q_,Q-dimethyl
Q-(2,4,5-trichlorophenyl) phosphorothioate].

They are organophos-

phate insecticides that control a wide variety of insect pests
including important forage insects (Collier and Dieter 1965; Gray
1965).

Table l lists representative organophosphate and organo-

chlorine insecticides that release halogenated phenols upon
metabolism or degradation .
It was found that Dursban residues remained relatively stable
when treated corn nlants were chopped and ensiled for 30 days
(Leuck et al. 1969).

Other studies showed that Dursban and

3,5,6-trichloro-2-pyridinol residues were found in the soil and

Table 1.

Representative Organophosphate and Organochlorine Insecticides with Phenolic Metabolites

Common Name

Chemical tlame of Systematic Name

Phenolic Metabolite or
Degradation Product

Dursban
( ch 1orpyri fos)

0,0-diethyl-0-(3,5,6-trichloro2-pyridy l) phosphorothioate

3,5,6-trichloro- 2-pyridinol

Ch loropyri fos-methyl
(Dowcor 214)

0,0-dimethyl-0-(3,5,6-trichloro2-pyridyl) phosphorothi oa te

3,5 ,6-trichloro-2-pyridinol

Leptophos (Phosvel)

0-(4-bromo-2,5 dichlorophenyl)0-methyl-phenyl phosphorothioate

4-bromo-2,5-dichlorophenol

Ronnel

0,0-dimethyl-0-2,4,5-trichlorophenyl phosphorothioate

2,4 ,5-trichlorophenol

lodophos (Iodofenphos)

0- ( 2, 5-di chl oro-4-i odophenyl)0,0-dimethyl phosphorothioate

4-iodo-2,5-dichlorophenol

Iodofenphos ethyl

0-(2,5-dichloro-4-iodophenyl )0,0 diethyl phosphorothioate

4-iodo-2,5-dichlorophenol

Trichlor metafos-3

0-methyl-0-ethyl-0-(2,4,5-trichlorophenyl) thiophosphate

2,4,5-trichlorophenol

0,0-diethyl-0-2,5,6-trichlorophenyl) thiophosphate
Bromophos (Nexion )

0- ( 4-bromo-2, 5-di ch lorophenyl)
0,0-dimethyl phosphorothioate

4-bromo-2,5-dichlorophenol

Table 1.

(Continued)

Co11111on Name

Chemical Name or Systematic Name

Phenolic Metabolite or
Degradation Product

Bromophos ethyl

0-(4-bromo-2,5-dichlorophenyl)
0, 0-d i ethyl phosphorothi oa te

4-bromo-2, 5-di chl oropheno 1

Gardona (stirofos)

2-chloro-1-(2,4,5-trichlorophenyl)
vinyl dimethy l phosphate

2,4,5-trichlorophenol

2,4,5-T

2,4,5 trichlorophenoxyacetic acid

2,4,5-trichlorophenol

Erbon

2-( 2,4,5-tri chl orophenoxy)ethy l 2,2dichloropropionate

2,4,5-trichlorophenol

Silvex (2,4,5-TP)

2-( 2,4,5-trichlorophenoxy)
propionic acid

2,4 ,5-trichloropheno l

Lindane ( y-HCH)

y-1, 2,3,4,5,6 -hexachlorocyc lohexane

2, 4,5-trichlorophenol

BHC

1, 2,3,4 ,5,6-hexachlorocyclohexane

2,4 ,5-trichlorophenol

Haloprogin

2,4,5 trichlorophenyl-yiodopropargyl ether

2,4,5-trichlorophenol

Trichlorobenzene

1, 2,4-tri chlorobenzene

2,4 ,5-trichlorophenol
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in plants (radishes and carrots) after one year from treated soil
in field plots treated with Dursban at 3.4 kg 1\.!/ha
Harris 1980; Smith et al. 1967).

1

~hapman

and

Leuck et al. (1969) examined and

reported the persistence of ch 1orpyri fos and its pheno 1 in forage
corn to be more persistent than those of most organophosphorus
insecticides.
Cows fed a complete ratio containing Dursban residue for 2
weeks showed residues of Dursban and 3,5,6-trichloro-2-pyridinol
in milk and cream samples (McKellar et al. 1976).

Residues of

chlorpyrifos and its metabolites 3,5,6-trich loro- 2-pyridinol,
were determined in fat, muscle, 1i ver, and kidney tissues of

s1~i

ne

at 1 week posttreatment with chlorpyrifos, but only in fat and
liver tissue at 2 weeks

posttreatment (lvey and Palmer 1979 ).

McKellar et al. {1972) found residues of chlorpyrifos predominantly
in fat tissue and 3,5,6-trichloro-2-pyridinol in liver and kidney
tissues of swine when the animals were fed chlorpyrifos in their
diet for 30 days.

The levels of the residues were small, ca .

0.05 ppm, even at the highest dietary concentration of 10 ppm.
The residues declined rapidly to undetectable or very lov1 levels
within 7 days after withdrawal of the insecticide from the feed.
Similar results were obtained when chickens were fed chlorpyrifos
(Dishburger et al. 1972) and when turkeys were confined in pens
on treated soil (Mann et al. 1973) .

Also, residues of 3,5,6-

trichloro-2-pyridinol were found to be greater in liver and kidney
than those found in fat when the cattle were fed chlorpyrifos in
their diet for 30 days (Di shburger et a 1. 1977).

Recently, it was

10
shown that the residues of 3,5,6-trichloro-2-pyridinol were found in
liver, kidney and fat of cattle wearing chlorpyrifos-impregnated
plastic ear bands (Ivey et al. 1978; Ivey 1979).

Smith et al.

(1967} reported that rats metabolized Dursban to 3,5,6-trichloro-2pyridyl phosphate (75 to 80%} and 3,5,6 - trichloro-2-pyridinol (15
to 20%).

Bakke et al. (1976) reported that rats metabolized single

oral doses of Dursban to at least six urinary metabolites.
urine contained about 90% of the dose.

The

Three of these metabo lites

were identified as the glucuronide of 3,5,6-trichloro-2-pyridinol
(80%}, a glucoside of 3,5,6 - trich l oro-2-pyridinol (4%), and 3,5,6 trichloro-2-pyridinol (12%}.

shm·~d

Also, Bakke and Price (1976)

that sheep and rats metabolized a sing le oral dose of chlorpyrifos
methyl (the dimethyl analogue of Dursban) to three major metabolites
that were excreted in the urine (70% of original dose) .
were the glucuronide of

3,5,6-trichlor~ · 2-py ridinol

These

(68.6%),

0-methyl-0-(3,5,6-trich loro- 2-pyr idyl) phosphorothioate (17.8%) ,
and 3,5,6-trichloro-2-pyridinol (13.8%).

The latter two metabolites

and the present compound were isol ated from sheep feces.

Sheep

pl asma contained the same metabolites that were found in sheep
urine.

However, in the same study it was found the sheep excreted

a sing le oral dose of 3,5,6-trichloro-2-pyridinol unchanged in the
feces and as a glucuronide in the urine.

Only the bile, liver,

kidney and gastrointestinal tract with its contents contained
detectable residues of 3,5,6-trichloro-2- pyridinol.
Although leptophos administered orally to mice is rapidly
metabolized and excreted as degradation products (Hol mstead

11

et al . 19 73), the major product was conjugated 4-bromo-2,5-dichlorophenol.

Leptophos is relatively persistent in the envirionmen t in

relation to other organophosphate insecticides (Leuck et al. 1969;
Braun et al. 1975; Leuck et al. 1970 ) .

Leptophos fed to dairy

cattle as residues on corn silage was observed to increase body
gain and decrease milk production while not affecting feed intake.
The cows ingested Leptophos residues averaging 0.41 to 1.71 mg/kg
body weight and all secreted mi lk containi ng both Leptophos and its
phenol .

Also, Leptophos and its phenol were excnted in feces, but

only phenol was excreted in t he urine (Johnson et al . 1971) .

The

chemica l properties of Leptophos suggest that this pesticide may be
deposited in the fat of animals (Davies et al. 1975; Freed et al .
1976).

Recently, it was shown that Leptophos is rapidly absorbed

by adipose tissue of hens after a s ingle oral dose (Nabuhiro and
Hideo 1978).

Leptophos reduced the number and wei ght of eggs laid

(Abo u-Don ia and Preissing 1976).

Urinary excretion of 4-bromo-2,

5-dichlorophenol metabolite of Leptophos was found to be 12% of the
tota l administered dose in rats (B r adway et al . 1977).

Also 4-bromo-

2,5-dichlorophenol was found as a metabolite of Leptophos in the
white mouse urine, cotton plants and houseflies (Holmstead et al .
1973 and Lee and Fukuto 1976).
Ronnel, in addition to its use as an insecticide, has been shown
to enhance feed efficiency and improvf' 1·•eiqht gain in beef when
directly employed as a feed additive (Ramsey et al . 1975).
Bradway et al. {1977) reported t hat rats excreted single oral dose s of
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Ronnel as 2,4,5-trichlorophenol (40.8 to 46.9% of the administered
dose) in urine.

It was found that Iodophenphos ethyl was inactive

while its metabolite 2,5-dichloro-4-iodophenol was more active
than 3,5,6-trichloro-2-pyridinol (Abo-Khatwa and Hollingworth 1974),
to stimulate oxygen uptake both in the presence and absence of
phosphate in vitro rat with liver mitochondria .
In studies with radioactive iodophenphos (14C) in rats, it was
shown that elimination of iodophenphos

equivalents in rat urine

and feces accounted for 92% of the dose in 24 h after oral treatment.

Greater than 98% of the total of the radioactivity in the

urine was in the form of acidic metabolites (Frederick and Charles
1970).

Recently, Ivey and Oehler (1976) studied the metabolism of

iodofenphos which is used systemically to control a variety of ticks
on livestock.

They detected 4-iodo-2,5-dichlorophenol in tissues

and urine of cattle fed iodofenphos.
4-Bromo-2,5-dichlorophenol was found to be the main metabolite
of bromophos in tomato plants, reaching 13% of the total dose applied
after 7 days (Stiasni et al. 1969).

That metabolic pattern in

plants is identical with that found in rats (Stiasni et al. 1967).
Organochlorine compounds (organochlorine insecticides and
polychlorinated biphenyls) have become major environmental pollutants.

They have been used for several decades in agriculture and

industry.

Their low degradation in nature, their accumulation in

livi ng bei ngs, their biomagnification (increase of residue in the
food chain) and their biological effects in natural exposure and
animal experimentation may create environmental problems, in part
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by increasing halogenated phenols in the environment.

Chlorophenols

are major metabolites of many organochlorine compounds.

Some of

these compounds were listed in Table 1.
Examples of biota contamination with chlorophenols following
specific pesticide usage are numerous in the literature.

For

example, Fitzgerald et al. {1967) showed the degradation of 2,4,5trichlorophenoxyacetic acid (2,4,5-T) in wood plants led to 2,4,5trichlorophenol.

Also, 2,4,5-trichlorophenol was found in sun-

flower seedlings and strawberry leaves after treating with 2,4,5-T
(Chkanikov et al. 1970).

Recently, it has been found that 2,4,5 -

trichlorophenol is produced from 2,4,5-trichlorophenoxyacetic acid
in soil and water (Rosenberg and Alexander 1980).

Clark et al. {1975)

reported tissue residues of 2,4,5-trichlorophenol in sheep and cattle
given oral doses of the herbicides 2,4,5-T and silvex.

Liver and

kidney contained the highest levels and withdrawal of the animals
from treatment for 1 week before killing resulted in significant
reduction in tissue residue level.

2,4,5-trichlorophenol was found

to be the principal metabolite of the 4-(2,4,5-trichlorophenoxy)butyric acid herbicide following ora l administration to rats (Boehme
and Grunow 1974).
Erbon , 2-(2,4,5-trichlorophenoxy)-ethyl-2,2-dichloropropionate
is a herbicide used extensive ly i n noncrop areas to control weeds
and grass.

Erbon is more toxic than other members of the 2,4,5-T

herbicide family.

2,4,5- trichlorophenol was found in blood, urine

and feces shortly after administ r ation of erbon given orally
to sheep and the highest residue level of 2,4,5- trich l orophenol was
found in the kidney, liver and fat (Wright et al . 1970).
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In 1965 Grover and Sims showed that rats metabolized both lindane, y-1 ,2,3,4,5,6-hexachlorocyclohexane (y-HCH) and ( y-PCCH)
y-2,3,4,5,6-pentachlorocyclohex-1-ene to 2,3,5- and 2,4,5-trichlorophenol which are excreted in the urine as free phenols, sulfates,
and glucuronic acid conjugates (Chadwick and Freal 1972a and b;
Freal and Chadwick 1973).

Recently it was shown that lindane and

hexachlorocyclohexene administered to rats produced 2, 4,5-trichlorophenol as one of the many other chlorophenol metabolites
both in vivo and in vitro (Chadwick et al. 1975; Tanaka et al.
1979a) .

Tanaka et al . (1979b) showed the metabolic fate of pol y-

chlorocyclohexenes [1,3,4 ,5,6-pentachlorocyclohexenes (PCCHE) and
1, 2,3 ,4 , 5,6-hexachlorocyclohexene (HCCHE)] using mic rosomes from
rat liver and housefly abdomen.

They found that PCCHE and HCCHE

were metabolized to 2,4,5-trichlorophenol as one of the many other
chlorophenol metabolites .
Weikel and

Bartek (1972) reported that, in the rat and rabbit,

most of the administered dose of haloprogin, 2,4,5-trichlorophenyl8-iodopropargyl ether , an antifungal agent, was excreted in urine
as the major metabolic products 2,4,5- trichlorophenol and its
sulfate conjugate .

Also, 2,4,5 and 2,3,5-trichlorophenol were

identified as major rabbit urinary metabolites of 1,2,4-trichlorobenzene (Kohli et al. 1976).
It is well known that organochlorine pesticides are soluble
in fat and persistent for a long time in the tissue of animals.
On the other hand, halogenophenols are major metabolites of many
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organophosphorus and some organoch l orine pesticides, which in general,
are readi ly biodegradable as shown before .

As of this date, there

has been very little work reported in the literature about distribution of the halogenated phenols and pyridinols in the tissues.
Most of the studies were limited to the determination of urinary
excretion of some halogenated phenol metabolites of biodegradable
pesticides.
Relation Between Chemical Structure and Biological Activity
The question of whether there would be some relationship between
chemical structure and biological activity arose as early as the
last century, and once it appeared possible to extend the range of
drugs gradually by synthetic routes, ma ny efforts were made to find
an answer (Albert 1971).
There are numerous examples to substantiate the claim that
studies on the relationship between the structure of a substance
and its activity in biological systems have great practical va l ue
and have made significant contributions to the understanding of
biological phenomena in general.

The term structure reiates to

the physical characteristics, such as solubility, surface area, and
molecular size, and the chemical factors of intramolecular electron
distribution, pK, state of charge and stereochemistry.

Any one,

all, or any combination of these parameters might be influential
in structure-act i vity considerations .

Exp loitations of

16
structure-activity relationship has at times led to the synthesis
of valuable therapeutic agents .
The Importance of Partition Coefficient
in Structure-Activity Relationship
The partition coefficient is one of the most important factors
in controlling the interaction of chemicals with biological systems
(Daniels et al. 1966).
Fundamental work was carried out by Richet (1893), who found
that the toxic effects of ethers, alcohols, aldehydes and ketones
are inversely proportional to their solubility in water; by Traube
(1904), who established a linear relationship between surface tension and activity for a series of narcotics; and by Fuehner (1907),
who noted the possibility of there being a quantitative relationship between a biological property, for example the narcotic
activity, and the number of carbon atoms.
All of this research may be viewed in conjunction with the
postulation of Crum-Brown and Fraser (1869) that the physiological
action, ¢ , of a molecule is a function of its chemical constitution
(C):

¢

=

f(C)

(1)

Meyer and Overton (1901) were stud.vinq independently the mode of action
of the indifferent narcotics or physical toxicants which are quite
diverse in structure and have depressant properties, especially
in cells that are particularly rich in lipids, such as nerve cells.

17
From their studies it was discovered that most organic compounds
foreign to the organism penetrate tissue cells as though the membranes were lipid in nature.

They also found that the passage across

these barrier systems and the subsequent narcotic action parallel
the oil-water partition coeffic ients of the structures investigated
( Rekker 1977).
While it has become apparent that biological activity can
rarely be coupled to a single parameter but should rather be
envisaged as the result of the interplay of various parameters,
the partition coefficient did remain the major parameter in structure activity relationship studies.

The period between the research

of Meyer and Overton and the present situation is about half a
century.

For a review of the most important events during this

period, reference is made to Purcell et al. (1973).

Rekker {1977)

outlined the following improved parameters that are meaningful for
the understanding of biological action and the better approaches
used in structure-activity studies:
( 1)

Hammett substituent constants
Hammett (1937) was among the first to offer a quantitative

treatment of the effects of structure on chemical activity.

His

equation {2) makes it possible to calculate a rate or an equilibrium
constant of a meta- or para-substituted derivative of c6H5-R with
R as the reacting center:

Log

~:

; PO

(2)
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where, K0 represents the equilibrium constant of an unsubstituted
structure and Ks that of a substituted derivative.

The symbol cr

is called the substituent constant, reflecting its ability to
attract or repel electrons.

Electron withdrawing groups have

positive substituents, with respect to hydrogen.

The symbol p

is the rection constant in equation (1), and measures the sensitivity
of the reaction to electronic effects on them, p-substituents .
l'hen the log of the dissociation constants of various substituted
benzoic acids is plotted as a function of the substituent constant
of t he same compounds , meta and para substituents fall on a straight
line .

Ortho-substituted compounds deviate because of steric inter-

fer ence, but when thes e s t eric interferences are removed by operating
in the gas phase, the ortho substituents fall on the line .

The

Hammett treatment has been app 1i ed to many reactions and fun ction a 1
groups, and correlates well with a substantial amount of data
(Jaffe 1953).

Since t he electronic effects of substitutions as

conducted by the Hammett method proved to largely determine the
partitioning behavior of a series of analogues, the biologi cal processes highly dependent on distribution of the chemical, can often
be correlated with the Hammett constant.
(2) Hansch approach to structure-ac t ivity relationship
After the Hammett a-constant was found useful in evaluating
the chemical constitution of a molecule upon which biological
activity is highly dependent, Hansch et al. {1963, 1964 and
1965a and b) found an alternatively very useful structure-activity
correlate, by use of

Tr .

This

\~as

defined as
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p

rr = log (__l_)
PH

(3)

where Px and PH are the octanol-water partition coefficients of a
parent compound H and its derivative X, differing by a substituent
group.

Thus the constant rr indicates the change in the logarithm

of the partition coefficient resulting from the introduction of the
substituent group.
The rr values for many substituent groups were directly measured
by Hansch et al . (1964 , 1965b) for a variety of drugs (over 200
aromatic compounds) and used in order to calculate the lipophilic
character, as expressed by the partition coefficient function log
or by Err of other compounds.
Hansch and Fujita (1964) offered statistical models to explain
the relationship between structure and biological activity, and to
reduce it t o a series of linear regression equations .

They take

a logical approach to the penetration of a compound to the active
site and the subsequent response evoked.

It was assumed, as a

first approximation, for many types of biologically active mole cules there is one key rate-contro l ling reaction at the active site.
This is formulated as in equation (4).
. 1og1ca
. 1 responses
Rate of b10

= d(response)
dt
= ACK x

A is the probability of a molecule reaching a site of action in
a given time interval, Cis the extracellular molar concentration
of the compound being tested and Kx is a constant.

1, 4 )
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Thus, it was held that the biological response is a function
of how much is applied, how successful the compound is in reaching
the target, and how it reacts once it arrives.
a direct result of the molecular structure.

These factors are

On the same studies,

Hansch and Fujita (1964) developed five types of regression eq uations to fit various types of biologically active structural series .
The simplest case was des ignated as Type I, which is given by the
following equation:
1

Log C =

(5)

a rr + b

where C is the concentration required for a definite effect-usual ly
EC 50 .

The symbols a and b represent the slope and intercept,

respectively.
lipophilicity.

The activity of compounds in this type varies

wit~

Examples of type II activity are given in equation

(6), which is represented by the action of phenols on Salmonella

typhosa and the carcinogenic activity of the dimethylaminoazobenzenes.
Log

t

=

-a rr 2 + b rr + C

(6)

The other types, represent more complex situations, including factors for electronic and steric effects.
(3)

Boyce and Milborrow approach to structure and biological
activity
Hansch et al. (1965) pointed out that the calculated parti-

tion coefficient log P or Err cannot completely replace the
experimental determination of partition coefficient because of
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possible group interactions, and Bird and Marshall (1967) found
some anomalies in the calculated Ln values of penicillins.

On the

other hand, in order to avoid the practical difficulties of the
direct determination of a partition coefficient, particularly when
the compound is highly insoluble in either of the solvent phases,
Boyce and Milborrow (1965) suggested the use of the chromatographic
Rm value as a simplified assessment of partition coefficient and
its derivatives by exploiting the theoretical relationship between
partition coefficient P and Rf value deduced by Martin (1949) for
liquid-liquid partition chromatography:
(7)

where K is a constant for the system.
Bate-Smith and \·J estall (1950) introduced the term Rm, shown
t o be related to the partition coefficient and calculated from
the formula :
R

m

=

Log (..l_ - 1 )
Rf

(8)

T1us, equation (9) can be used in place of equation (7)
Log P

=

(9)

Log K + Rm

T1e change in the value of Rm for a substituent

(ll~)

e1ergy-based constant analogous to n used by Hansch.

is a free
It is there-

fJre possible in principle to correlate the penetration of substances
with their

~

va 1ues.

As a cora 11 ary of this,

h1ve a linear correlation.

~

and n usually

One of the purposes of the present
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work is to show that reversed phase thin layer chromatography is
a suitable technique and simple and rapid method for the determination of lipophilicities for halogenated pheno l s and pyridinols.
The lipophilic nature of a series of compounds has been described
by Boyce and Milborrow using this approach (1965), and it has
frequentl y been used since, for example, by Biagi et al. (1969 ,
1970 ).

The chromatographic Rm value determination is more con-

venient than measuring partition coefficients (Dearden et al . 1974) .
Studies of the Relationship Between
Molecular Structure of Halogenophenols
and Chromatoaraphic Behavior
To date, there are very few papers in the literature dealing
with the relationship between structure of halogenoohenols and
pyridinols and chromatographic behavior.

Bark and Grnham (1966a)

chromatographed 60 halogenated and halogenoalkyl substituted phenols
on alumina surfaces in eight eluent systems.

They found the Rf

values of the phenols decreased with an increase in the number of
halogen atoms in the molecule thus indicating that the alumina surface acts as a proton donor towards the halogen atom as well as
towards the phenolic gro up .

It was seen that the Rf values of

analogous halogenophenols increased with an increase in the size
and corresponding decrease in the electronegativity of the halogen
atom.

In the same year, Bark and Graham (1966c) studied the

chromatographic behavior of halogenated phenols, chromatographed
in the reversed-phase thi n layer chromatographic system ethyl
oleate-aqueous ethanol.

They suggested the mechanism of the
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chromatographic process is dissol ution of the phenol in the hydrophobic stationary phase, followed by the remova l of the phenol from
the interface as a resu l t of solvation of the pheno l ic group by
the polar mobile phase.

They also fou nd that the Rf values of

halogenated phenols decreased with an increase in the number of
halogen atoms in the molecule.

This suggested that the effect of

partial molar volumes of the halogen atoms is more important in
governing the separation process than are electronic effects .
It was shown that the number and nature of the substituents
and their relations will have an effect in determining the chro matographic behavior of a compound (Bark and Graham 1966b).

For

the series of monohalogenated phenols, fluoro-, chloro-, bromo-,
iodo-, Marcinkiewicz and Green {1963) found separations to occur
according to the molar volumes of the halogen atoms.
Graham also found the order of Rf values to be:

Bark and

fluoro < chloro <

bromo < iodo, i.e . , in order of the molar volumes of the halogen
atoms.

Bark and Graham {1967) reported that the migration of

halogenated phenols was related to the site of solvation of the
molecule by the mobile phase, the solvation site being the hydrophobic part of the molecule for the non-aqueous eluent and the
phenolic group for the acqueous eluent .

They suggested that the

above mechanisms may be influenced by a number of factors such as
el ectron withdrawal or donation by the subst i tuent gro ups,
steric effects and position of substituents in the mo l ecule.
these were shown to affect the Rf values.

Al l
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It is well known that atoms within groups in molecules tend to
attract or release electrons to other regions of the molecule,
depending on the electronegativity of the atom.

This alters the

intramolecular distribution of electrons, making some region of
the molecule electron-deficient and another electron - rich.

Examples

of substituent groups with electron withdrawing capacity are nitro,
quaternized nitrogen, cyano, carboxyl, and chlorine, whereas some
groups that release electrons are hydroxyl, methoxyl, methyl,
amine, and phenyl.
The distribution of a phenol between an aqueous and a lipoid
solvent can be approximately calculated by use of the n constant
for each substituent, as derived by Hansch (Fuj ita et al. 1964) .
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MATERIALS AND METHODS
Experimental Animals
Male weanling rats of the Sprague-Dawley strain, weighing 145
to 170 g, were purchased from Simonsen Laboratories, Inc. of
Gilroy, California.

They were individually housed in stainless

steel cages with wire mesh bottoms.

The rats were fed Purina

Laboratory Chow in cubed form ad libitum with fresh water prior to
and throughout the study.

The caqes were cleaned daily and the

rats were observed for six days before dosing with the test chemicals.
Chemicals Tested
The compounds used in the studies are presented in Table 2,
together with the data on source, purity and structural formula.
Experimental Desiqn
Experimental animals were randomly assigned to treatmen ts , and
adjustments were made to equalize the body wei ght within ±2 g in
each treatment, so that differences in group weights might not be
a factor.
Seventy-two rats were allocated into five 9roups comprising
16, 16, 16, 16, and 8 rats, respectively.

Rats in groups 2, 3,

and 4 were divided into two equal subgroups to make eight rats for
each treatment.

The subgroups were used with administration of the

higher dose level of 2,4,5-trich l orophenol, 4-bromo-2,5-dichlorophenol
and 3,5,6-trichloro -2- pyridinol.

Each rat, except for those in
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Table 2.

Compounds Used in Investigation, Including Chemical Structure, Purity and Sources

Compound

Structure

Purity

2,4,5-trichlorophenola

94%

4-bromo- 2, 5-dichlorophenolb

99.1 %

4-iodo- 2,5-di chlorophenolc

94%

3, 5, 6-tr i chloro- 2py r i di nold

Cl
Cl-Q-OH

99%

Cl

aProvided by Aldrich Chemical Company, Inc., Milwaukee,
Wisconsin .
bProvided by Velsicol Chemical Company, Chicago, Illinois.
cProvided by Agricultural Division of CIBA-GEIGY Corporation,
Greensboro, North Carolina .
dProvided by Dow Chemical Company , Midland, Michigan.
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group 1 (controls) was treated with a single dose of a test chemical.
Two rats from each treatment were killed at 1, 3, 6, and 12 day(s)
after administration of the compounds, as were two control rats.
Dose Administration
The dose level s of all compounds were based on the LDSO of
2,4,5-trichlorophenol because the LD50 values of the other compounds
were not available.

Dose levels of 0.4 and 0.08 of the LD50 (1.66 m

moles/kg and 0.33 m mo les /kg respectively) were used for each
compound under study (except 4-iodo-2,5-dichlorophenol which
tested only at the lower dosage).

~1as

The lower dose 0.33 m moles/kg

is equivalent to 65.6, 80.4, 95.9 and 65.9 mg/kg for 2,4,5-trichlorophenol, 4-bromo-2,5-dichlorophenol, 4-iodo-2,5-dichlorophenol and
3,5,6-trichloro-2-pyridinol, respe ctively .

The higher dose 1.66 m

moles/kg is equivalent to 328, 401.9, and 329.5 mg/kg for 2,4,5trichlorophenol, 4-bromo-2,5-dichlorophenol and 3,5,6-trichloro-2pyridinol, respectively.

The compounds were administered by gavage

as so lution in corn oil.
All compounds dissolved in corn oil, except 3,4,6-trichloro2-pyridinol which was dissolved in 1:9 v/v of ethanol and corn oil.
The concentrations of the compounds in solution were adjusted so
that each animal received 0.5 ml of the corn oil solution per 100 g
of body weight.

The control rats received an equal quantity of pure

corn oil.
Animal Termination
Rats were anesthetized by placing them into a jar in which the
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air was saturated with d·i ethyl ether.

At this time

was removed as possible via the dorsal aorta.

as much blood

Animals were then

sacrificed immediately and the liver, kidneys and the peri-renal
plus sub-cutaneous pockets of adipose tissue were dissected free
and cleaned of extraneous tissues.

Except for blood, the sample

tissues were weighed, placed in labeled vials and quickly frozen
for storage until they were analyzed (within three months).

Blood

was analyzed within 24 h after beinq drawn.
Apparatus
63

A Micro-Tek 220 gas chromatograph (GC) equipped with

Ni

electron capture detector (ECD) and a 6 ft x l/4 in . glass column
packed with 4% SE-30 + 6% QF-1 on 80-100 mesh chromosorb
was used.

VI

(HP)

The column was operated under the following parameters:

nitrogen carrier gas flow rate, 60 ml/min; column temperature,
170 °C; inlet, 2l0°C; detector, 275°C .
Solvents and Reagents
All solvents were pesticide quality or nano-grade (Fisher
and Baker).

Deionized water was used throughout the procedures and

was extracted with benzene.

N-ethyl-N'-nitro-N-nitrosoquanidine

(Aldrich) was used to prepare the ethylating reagent according to
Stanley ( 1966).

The silica ge 1 (Woe lm, active grade 1) was prepared

according to Shafik et al. (1973) .
Residue Analysis
Procedure for blood.

Blood was analyzed for residues using

modification of the methods in the Manual of Analytical Methods
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(Thompson 1979).

Extracting was by adding to 2 ml blood contained

in a round-bottomed tube 1 ml of 4% trichloracetic acid, 2 ml of
2% Na 2so 4 , and 6 ml of hexane.

The mixture was rotated in a Rotc-

rack at 50 rpm for 2 h, then eentrifuged at 2000 rpm about
to separate the layers.

min

Five ml of the hexane extract was trans-

ferred to a 15 ml graduated centrifuge tube and the organic residue
was extracted on a Roto-rack with 6 ml methylene chloride as before.
Five ml of the CH 2Cl 2 was combined with the hexane extract. Ten
drops of keeper solution (1 % paraffin oil in iso-octane) were added
to the combined extract solvent which was then concentrated to 0.5
ml by using a nitrogen evaporator (Meyer N-evaporator) .

One ml of

benzene was added followed by freshly prepa red diazoethane so l ution
dropwise until a definite yellow color persisted.

After allowing

the mixture to stand 15 min, any excess reagent was removed
by bubbling dry nitrogen through the solution.

The derivatized

sample was then "cleaned up" by use of the deactivated silica gel
procedure of Shafik et al. (1973).

The first fraction was collected,

concentrated to an appropriate volume, and analyzed by EC-GC.
Procedure for liver and kidney.

Four grams of liver or one

kidney {0 . 7-1.0 g) was extracted by blending in a Lourdes homogenizer with 100 ml acetone and filtered through Whatman 40 filter
paper into a 500-ml Erlenmeyer flask.
were washed with acetone .

The homogenizer and filter

A Snyder column was attached to the flask

and the extract was reduced by distillation to 25 ml and cooled to
room temperature.

An aliquot of the extract was taken for lipid

analysis while the remaining extract was transferred to a 125 ml
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separatory funnel and the sample extracted with benzene as described
by !vey et al . (1978).

The benzene extracts containing 2,4,5-

trichlorophenol, 4- bromo-2,5-dichlorophenol or 4-iodo-2,5-dichlorophenol were transferred to the alumina column for cleanup as described by Bowman and Bereza (1969).

In the case of 3,5,6 - trichloro-

2-pyridinol, the extract was cleaned up with the same method of
Ivey et al. {1978).

The eluate containing the halogenated phenols

or the pyridinol was concentrated in a flash -evaporator under water
pump vacuum to 50°C to near dryness and transferred to a 15 ml
graduated centrifuge tube.

Freshly prepared diazoethane reagent

was added drop-vlise until a persisting ye llow color occurred, and
the reaction mixture was then allowed to stand for 15 min.

Excess

reagent was removed by bubbling dry nitrogen through the solution.
From this point on the silica gel column cleanup method of Shafik
et al. (1973) was followed . The first fraction was collected,
concentrated or diluted to an appropriate volume and analyzed by
EC-GC.
Procedure for adipose tissue.

An 8-10 g sample of fat was

extracted by blending in a Waring blender with 75 ml acetone.
The homogenate was transferred to a 600-ml beaker, heated on a
hot plate to near boiling, and fi 1tered through l'ha tman 40 filter
paper into a 500-ml Erlenmeyer flask.

The blender, beaker, and

filter were washed thoroughly with acetone.

The filtered mass

was returned to the blender, blended with hexane, fi l tered into
a 300-ml Erlenmeyer flask, and washed with additional hexane.

A

Snyder column was attached to the acetone f l ask and the extract was
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reduced to ca 30 ml by distillation and cooled to room temperature.
The column was removed, and the corresponding hexane extract was
transferred to the flask containing acetone.

The Snyder column was

replaced, and the extract was again reduced to ca 75 ml (until the
solvent vapors in the Snyder column reached 63 - 64°C, a temperature
that indicates the absence of acetone).

The extract was transferred

to a 500 ml separatory funnel and partitioned 3 times with 50 ml
portions of acetonitrile.

The acetonitrile extracts were combined,

reduced to ca 10 ml by distillation through a Snyder column, and
cooled to room temp erature ; 30 ml of hexane was added through the
column , and the column was removed.

The solvent was evaporated to

dryness and the residue was taken up in 5 ml of benzene .

Deriva-

tion and cleanup were then carried out and the analytical procedure
completed in an identical manner to the liver and kidney samples.
Because residues were to be calcu lated on an extracted fat basis,
the hexane solutio ns remaining after the acetonitrile extraction
were transferred to a tared flask, the solvent was evaporated, and
the fatty residue was weighed and recorded as sample weight .
Analytical Recovery Studies
Recovery studies were performed by adding known amounts of
standards to each type of tissue sample (Table 2).

After mixing,

the f~rtified tissue samples were carried through the analytical
proced ure in an identi cal manner to unfortified samples.

If

the control samples contained any halogenated phenol or halogenated
pyridinol, as found in the liver tissue for 2,4,5-trichlorpheno l
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and 3,5,6-trichloro-2-pyridinol, the amount was subtracted from the
appropriate value obtained during recovery studies.
Procedure for Lipid
The procedure used for total lipid analysis was that described
by Bragdon (1951), based on oxidation of the extracted lipid with
dichromate and spectrophotometric measurement of the resulting
chromate concentration.

Calibration wa s made with stearic acid as

a reference.
Reversed-Phase Thin
Layer Chromatography
To estimate the relative solubility characteristics of the
compounds tested for accumulation and distribution in the tissues,
a revet·sed-phase thin 1ayer chromatography procedure adapted from
Biagi et al. (1969) was utilized.

Chrom-Ar 500 (Mallinckrodt)

cut in strips of 190 by 180 mm was impregnated with a 5% silicone
oil (Dow Corning 200, 350 centistokes) in ether (w/v) solution for
2 min, and then air dried.

A solvent feed line was drawn 15 mm

from the bottom, and the origin at 30 mm.

Solutions of halogenated

pheno ls and pyri dinol s were spotted on the origin 10 mm apart (and
beginning 25 mm from the edge to avoid edge effects).

The mobile

phase consisted of 37.5% of v/v aqueous ethanol, saturated with
silicon oil.

The spotted chromatograms were suspended in eq uili-

brated chromatography chambers, allowed to equilibrate for 20 min,
then the chromatogram was lowered into the mobile phase to the
solvent feed line.

When the solvent front had reached a line 100 mm

from the origin, the chromatogram was removed and dried with the aid
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of a forced-air heater.

The halogenated phenols and pyrid inol s were

detected as yellow spots on a purple background by spraying the
eluted chromatograms with alkaline potassium permanganate (Bark and
Graham 1966a).
extremes.
spots.

The yellow spots were marked at their centers and

The Rf values were determined from the center of the

Each compound was chromatographed four times on four

separate chromatograms and from these values the mean and sta ndard
error of the mean were computed.

The Rm for each compound was cal-

culated from the following relationship:

~

=

rt - 1)

Log (

f

Equation (8) was introduced by Bate-Smith and vlestall (1950).

(8)

RESULTS
Animal Studies
No adverse effects were observed in any of the rats treated
with either the low dose level ( . 33m moles/kg) or higher dose
level (1.66 m moles/kg) of any compound used in these studies.
Gross appearance and behavior, mortality, food consumption, weight
gain, average body and organ :weight ratios were not affected by the
chemicals.

All animals were healthy and active in pre- and post-

administration periods, no deaths were observed and no significant
difference in the body weight was observed among those given the
compounds and the controls.

A decrease in body weight was noted

one day after the administration among the animals exposed to the
higher dose level of pyridinol; however, this was all regained by
the third day after administration . The kidney and liver weight
relative to the body weight was not altered by administered compounds, except a slight decrease in the liver was found in animals
treated with a high dose of 2,4,5-trichlorophenol.

These data are

presented in Appendices A and B.
Gas Chromatographic Analysis of
Halogenated Phenols and a
Pyridinol in Tissues
The percent recovery, limit of detection in part per billion
(ppb), and detector sensitivity in picogram (pg) for each chemical
are shown in Table 3.

These are based upon duplicate analyses of

the fortified tissues using the methods described.

The blood and
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Table 3.

Electron-Capture Detector Sensitivities, Limits of Detection
and Percent Recovery of Halogenated Phenols and Pyridinol

Compound

Tissue

Detector
Sensitivity
pg

Limit of
Detectabi 1i ty
ppb

Recovery*

2,4,5-TCP
4-Br-2,5-DCP
4-I- 2,5 -DCP
3,5,6- TC-2-Pyridinol

Blood
Blood
Blood
Blood

10.5
9.0
11.7
11 .3

0.5
0.1
0. 1
0.1

100 .0
88.6
83.9
89.6

2,4 , 5- TCP
4-Br-2,5-DCP
4-I-2,5-DCP
3,5,6-TC- 2-Pyr idinol

Fat
Fat
Fat
Fat

12 .0
10
13
12 .5

9.0
2.0
1.8
2.1

80.7
64.0
64.6
54.1

2,4,5-TCP
4-B r- 2,5- DCP
4-I-2,5-DCP
3,5,6- TC-2-Pyridinol

Kidney
Ki dney
Kidney
Kid ney

15. 0
11. 5
12.5
18.0

12.6
9.5
10. 0
9.5

104.4
69.0
86.8
69.0

2,4,5-TCP
4-Br-2,5-DCP
4-I-2,5-DCP
3, 5,6-TC- 2-Pyri di nol

Liver
Liver
Liver
Liver

12.0
10.0
11.5
14.3

9.7
8.9
6.0
11. 0

66.5
70.8
81.6
103.8

*Mean of duplicate analysis from addin g 300 ng or 250 ng of each
compound to the tissue.
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fat contro l samples contained no halogenated phenols or pyridinols,
but control kidneys and livers did contain a component which had
a retention time identical to that of 2,4,5-trichlorphenol and
3,5,6-trichloro-2-pyridinol.

Before the recovery data were calcu-

lated, the recorder response of this component was subtracted from
the 2,4,5-trichlorophenol or 3,5,6-trichloro-2-pyridinol response
obtained from the fortified samples.

No other interfering com-

ponent or halogenated phenol and pyridinol was detected in .chromategrams of the control samp le at a concentration exceeding its correspending level of detectability.

Figure 1 illustrates chromatograms

of halogenated phenols and pyridinol of fortified and control kidney
tissue samples.

A small interference peak was present in kidney

and liver treated samples analyzed for 2,4,5-trichlorphenol and
3,5,6-trichloro-2 -pyridinol, just beyond the 2,4,5-tri chlorphenol
and 3,5,6-trichlor-2-pyridinol peak on the trailing edge.

This

interference was not identified and it did not affect the determination of compounds present because the determination was based
on peak height.
Chromatographic Rm Value Determinations
as an Index of Lipophilicity
In this study, Rm values were experimentally

determi~ed

14 halogenated phenols and pyridinols as shown in Table 4.

for
The

common name, sources, melting points, purities, structural formulas
and Rm values are presented in Table 4.

Four of these compounds

were then selected to be used through the animal study because
they have been in use for severa l decades in agriculture and
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l. 3 , 5,6-TC-2-Pyrid i no l

2. 2 ,4,5-TCP

3. 4-Br-2 ,5- DCP
4. 4- I - 2,5- DCP
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Figure 1. Gas ch romatograms of hal ogenated phenols and pyrid i nol
of f or ti fi ed and control kidney t i ss ues of r ats .
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Table 4.

Common Name, ~·1elting, Sources, Purities, Structure Formulas
and Chromatographfc R Values of Compounds Tested for
Lipophilicity
m

Common Name
4-Brom3-2,5-dichlorophenol 99.1 % used
as received

3,5-Dichloro-2,6-dimethyl4-pyridinolc
99%, used as received

Structural
Formula

Bc~H
c~
No

CH3

Melting
Point

R ±S-g
m x

?PC

-0 . 0045±. 0003

320°C

1.234±.071

H

1

2,4-Dichlorophenolc
99.8% used as received

45°C

0.00

Cl-{)(,H

2,6-Dimethyl-4-pyridinolc
analytical grade, used
as received

CH~
No

0.00
H

CH3

Pentachlorophenol,b
used as received

188-189°C

-.640±.032

cPrH

Pentabromophenole
used as received

Br~H

229°C

- .632±.057
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Table 4.

(Co ntinued)

Common Name
3,5,6-Triceloro-2pyridinol.
99 % used as received

Structura 1
Formula

';d'
OH

4-Iodo-2 ,5-dichlorophenola
techni ca 1 grade,
used as received

Melting
Point

R ±S-g
m x

-.908±. 040

Cl

IQoH

-.231±.045

Cl
Trichlorophenolsb
2,3,4
2,3 ,5
2,3,6
2,4,5 - (95%)
2,4,6c
3,4,5
all recrystallized

2,3,4 ,6-Tetrachlorophenolb
technical grade ·
used as received

cfO-oH
3

77-78°C
58-59°C
53-54°C
64°C
67°C
98oc

+.04 2±.043
-.084±.02 1
- . 627±.064
+.035± .01 0
- .475±.032
+.2926 ±. 41

-. 720±.003

aProvided by Agricultural Division of CIBA-GEIGY Corporation,
Greensboro, North Carolina.
bPurchased from Aldrich Chemical Company, Inc., Milwau kee, Wis .
cProvided by Dow Chemical Company , Midland, Michigan.
dProvided by Velsicol Chemical Company, Chicago, Illinois .
ePurchased from K. K. Lab, Inc., Planeview, New York.
fMelting values of compounds not reported were not determined .
gMean of four chromatograms.
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industry, and as of this date, there has been very little work
reported in the literature relating to these compounds.

The Rm

was used in this study as the estimator of the relative lipophilicity of halogenated phenols and pyridinols.
Concentrations Based
on the Tissue Weight
Halogenated phenols and the halogenated pyridinol were differentially distributed in every tissue sampled following the
administrations.

These data are presented in Appendix D.

Figure

2 shows the corrected concentration of 2,4,5-trichlorophenol,
4-bromo-2,5-dichlorophenol, 4-iodo-2,5-dichlorophenol and 3,5,6 trichloro-2-pyridinol, respectively in selected tissues of rats
24 h after single oral administration of 0.33 m moles/kg or 1.66
m moles/kg.

All tissues showed different accumulation of halo-

genated phenols and pyridinol.

The average 24 h concentrations of

halogenated phenols and pyridinol in blood were 2 to 2.6 ppb in
animals administered 0.33 m moles/kg body weight, whereas the
average 24 h concentrations in animals dosed with 1.66 m moles/kg
were 16 . 9 to 17.4 ppb.

It seems there was no significant difference

among the 24 h concentrations of each compound observed in blood,
whereas significant differences among 24 h concentrations in fat,
kidney, and liver were readily observed.
The 2,4,5-TCP mean concentration in fat 24 h after administration
of 0.33 m moles/kg was found to be 247.1 ppb.

This value was 1.7,

1.7, and 15.9 times greater than that found for 4-Br-2,5-DCP,
4-I-2,5-DCP, and 3,5,6-TC-2-Pyridinol, respectively, in the same
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tissue.

The 2,4,5-TCP mean 24

with 1. 66 m moles/kg was about

concentration in animal fat dosed
and 2.7 times greater than that

found for 4-Br-2,5-DCP and 3,5,6-TC-2-Pyridinol, respectively.
The average 24 h value of 2,4,5-TCP concentration in kidneybased on the tissue weight (Figure 2) was elevated 1.1, 6.1, and
7.5 times over the values for 4-Br-2,5-DCP, 4-l-2,5-DCP and
3,5,6-TC-2-Pyridinol, respectively in animals administered 0.33
m moles/kg.

The kidney concentration of 2,4,5-TCP in animals

administered 1.66 m moles/kg was 2. 7 and 3.0 more than that of
4-Br-2,5-DCP and 3,5,6-TC-2-Pyridinol values, respectively .
The average value of liver 3,5,6-TC-2-Pyridinol concentration
24 h after administration was found to be more than 3. 6, 4.5 and
9. 8 greater than values that were found for the liver 4-Br-2,5-DCP,
4-I-2,5-DCP and 2,4,5-TCP, respectively, in animals given 0.33 m
moles/kg.

The liver 3,5,6-TC-2-Pyridinol in animals administered

1.66 m moles/kg was 7.7 and 26 times over the values found for
liver 4-Br-2,5-DCP and 2,4,5-TCP, respectively .
Concentrations Based on
the Lipid Weight
Figure 3 illustrates the concentration of halogenated phenols
and pyridinol in the selected tissues calculated on a tissue lipid
basis 24 h after single oral administrations of 0.33 m moles/kg
and 1.66 m moles/kg .

The average 24 h concentration of all com-

pounds based on tissue lipid content, follow the same order and the
same pattern as the 24 h concentration based on tissue weight.

The

only difference found was that the 24 h concentrations of all compounds were higher on a tissue lipid basis than that found on
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tissue weight basis, especially for 3,5,6-trichloro- 2-pyridinol in
liver.

The concentrations of halogenated phenols and pyridino l on

a tissue weight basis and on tissue lipid basis after administration 0.33 m moles/kg and 1. 66 m moles/kg are presented in Appendix D.
Depletion of Halogenated Phenols
and Pyridinol in Tissue
The halogenated phenols and halogenated pyridinol used in this
study were distributed in every tissue sampled following their
administrations.

Figures 4, 5, 6 and 7 show the concentration

of 2,4,5-TCP, 4-Br-2,5-DCP, 3,5,6-TC-2-Pyridinol and 4-I-2,5-DCP,
respectively, in selected tissues of rats after a single oral
administration of 0.33 m mo les /kg or 1.66 m moles/kg at different
time intervals.

With the exception of liver, in the case of 3,5,6-

TC-2-Pyridinol, and kidney in the case of 2,4,5-TCP, all residues
in tissues declined rapidly
log linear fashion.

~lith

time but not always in an apparently

The rates of decline were different for the

different tissues and for the different compounds.

Generally,

concentrations of all compounds at 24 h after treatment were
depleted by 96% or reached undetectable limits on the sixth or
the twelfth day for animals given either dose.

The only exception

found was the 2,4,5-TCP concentrations in blood and kidney which
slowly depleted by 10% and 21 % of the 24 h peak concentration,
respectively, on the third day, and proceeded rapidl y on the sixth
day after treatment with 0.33 m moles/kg (Figure 4).

On the

other hand, the kidney 2,4,5-TCP 24 h concentration depleted by
44.5% on the third day, after which the rate of depletion was very
slow; apparent persistence between the third and the sixth day
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Figure 4. Depletion of 2, 4,5-trichlorophenol i n blood, fat, kidney,
and liver tissues of rats following a single ora l ly administered
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broken lines indicate the termi nal depletion to the minimum limit of
detection (x) .
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was observed (Figure 4).

By the twelfth day depletion reached 96.7%.

Also the initial rates of the liver 3,5,6-TC-2-Pyridinol 24
concentration rapidly declined in the first three days then declined
more slowly from that time on (Figure 6).
Table 5 presents the tissue :b lood ratios of halogenated phenol s
and pyridinol at varying time intervals after single oral administration 1.66 m moles/kg.

These ratios indicate that the rate of

decline of halogenated phenols and pyridinol in blood were greatest
when compared to other tissues, therefore, the ratios increased as
time increased.

With respect to blood, all tissues showed accumu-

lation of halogenated phenols and pyridinol with time.

The highest

accumulation of administered halogenated phenols was in kidney,
followed by fat and liver, which showed the least accumulation;
whereas the highest accumulation of halogenated pyridinol was in
liver, followed by kidney and fat, respectively.

Table 6 presents

the tissue:blood ratios of al l compounds used in the study at
varying t ime intervals after administration of a single oral dose
of 0. 33 m moles/kg body weight.

The higher tissue:blood ratios of

residues following the low dose of these compounds (Table 6)
indicates a proportionally more rapid clearance of the blood
and distribution of residue to tissues than that occurring with
the higher dose 1eve 1 (Tab 1e 5).
Distribution in Organs
Data on the distribution of halogenated phenols and pyrid inol
in organs are shown in Appendix C.

Following administration, each

of the halogenated phenols and pyridinol was rapidly removed from

Table 5.

Tissue:Blood Ratios of Halogenated Phenols and Pyridinol at Various Ti me Periods After the
Single Administration of a 1.66 m moles/kg Dose in Ratsa

Time days
Compounds

Tissues

1

2 ,4,5-trich1ororheno 1

Fat
Kidney
Liver

40.6+5.7
30.4+4.1
5.2 ~-0.4

fi3.5 + 47.1
81. l + 11.3
12.7 3::1.7

37.4 + 5.3
33Q.5-+ 145.0
7. 2 ~ 2.9

*29 .8 + 0. 9
*?.5.7 + 2.5
*fi . 99 3:: 2.9

4-bromo-2 ,5dich1oropheno1

Fat
Kidney
Liver

21.8 + 15.1
37.5 + 3.2
19.7 3:: fi . 3

92.5 + ?.4.2
234.1-+ 34 . 1
11 3.13::41.5

50.9 + 6.3
102.'l-+ 17.2
S0.5 ~-1 9.9

ND .

Fat
Kidney
Liver

15.1 + 3. 1
13.9 + 0.1
133.4-.:!:. 20. 1

40.6 + 32.8
242. 4-+ 107.7
1272 .4-.:!:. 108.4

3'l.O + 0.01
3'l.5 + 0.0
24 38 .3.:!:_ 102.3

ND
*7.5 + 0.02
*1989-:-3.:!:. 529.5

3,5,6-trichloro2-pyridinol

3

12

fi

92 . <1

~

43.8

ND

aMean ± SE of two animals in eac h case. The values were obtained by dividing mean tiss ue
concentration by mean blood concentration for each animal .
*The values were obtained by dividing mean tissue concentration by lower limits of detectability
of blood concentration.
ND ~ not detected in kidney, liver and fat.

Ol

0

Table 6.

Tis s ue:Blood Ratios of Halogenated Phenols and Pyridinol at Various Time Periods After Administration of a 0.33 m moles/kg Dose in Ratsa
Time days
3

li

122.8 + 80.6
171.1 + 2.8
22.9 :!:.- 6 . 9

57.3 + 5.9
7S . Cl t 14.7
21.0 ~ 4.2

*47.9 + 21.9
*326. 4-+ 71 .6
*40.4 :!:.- 0.1

*311. 1 + n. 1
*17 . 3 ~ 7 . 2
ND

Fat
Kidney
Liver

f\4.3 + 42.8
149 . 9-+ lfi . ()
51. 2 ~ 2 . 3

195.3 + l 4Q.3
567 .4 t Hl6.3
21.3 +-9.5

*fln.5 + 31i.5
*525.4-:!:_l'l.S
NO

*42 . 4+0.1
*147.3-:!:. 37.6
ND

4-i odo- 2 ,5dichlorophenol

Fat
Kidney
Liv e r

61. 7 + 7. l
63.6 + 0 . 9
59 .0 ~ 15.8

91.4 + l5 .fi
169 .6-+ Q. 3
25 .0 +- 4.8

*23 .4 + 111 . 1
*20 . 7 + 0. l
*13.2 ~ 3.6

ND
ND
*lfi . 7 :!:. 1.7

3, 5, 6- tri ch l oro2-pyri di no l

Fat
Kidney
Liver

6. ~ + 2.6
22 . 5- + 0 . 2
203. 7-:!:. 84.3

31.7+ ?. 4.4
37.6 + 28.9
6fl3.5-:!:. 131.7

*39.6 + 26.f\
92.0 +-0 .6
*313.6:!:. Ql.2

*?.0.2 + 'l.O
*55.2 +- 1 .5
*l Q4.'l:!:. 28.1

Compounds

Tis s ue

2 ,4,5-tri ch l oropheno l

Fat
Kidney
Liver

4-bromo-2 ,5dichlorophenol

l

aMean ± SE of two animals in each case.
mean bl ood concentration for each animal.

12

The values were obtained by dividing co ncentrat i on by

*The values were obtained in dividing mean tissue concentration by lower limits of detectability
of blood concentration .
NO = not detected in kidney, liv er and fat.
~
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the blood and accumulated in the fat and liver and followed by the
kidney.

The highest content of halogenated phenols was in fat,

whereas, the highest organ content of the halogenated pyridinol
was in liver.

The percentage of each chemical in the whole organ

relative to the administered dose is given in Appendix C.

The

content of chemicals in the whole organ at 24 h after administration was depleted, approximately by 96%, or reached undetectable
limits on the sixth or twelfth day .

All compounds appear to be

redistributed from blood and perhaps other tissues, thus fat and
liver decline rates become slow relative to blood.
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DISCUSSION
Animal Studies
No evidence whatsoever of adverse effects were observed in rats.
The decrease in body weight which was observed after one day postadministration of the higher dose (1.66 m moles/kg) of the pyridinol
was probably due to feed avoidance.

However , the decrease in body

weight was regained by the third day after dosing .

McCollister et al.

(1961) reported that the repeated oral administration of 0.1 g/kg/day
of 2,4,5-TCP to rats for 24 days produced no adverse effects; whereas
rats maintained at 0.3 to 1.0 g/kg/day for 24 days showed
sible pathological changes in the liver and kidneys.

mil~

rever-

However, at

1.0 g/kg, the only effect attributable to 2,4,5-TCP was a slight
increase in average weight of the kidneys.

Anderson et al. (1949)

fed groups of cattle dosages of 0.8, 2. 4, and 7. 2 g per 100 pounds
of animal weight per day of zinc, 2,4,5-trichloro-phenate and 2,4,5trichlorophenyl acetate in the diet for 78 days. They observed no
adverse effect at any of the levels fed.

Beck (1976) reported that

halogenated phenols and pyridinols, when fed to rats at 100, 200,
and 400 ppm in their diet, did not show significant difference in
feed efficiency (weight gain/feed consumed) from controls.

In light

of the above, it would be safe to say that halogenated phenols and
pyridinol are low in oral toxicity when the rats are given single
oral doses at 0.33 and 1.66 m moles/kg.

The lower dose, 0.33 m

moles/kg is equivalent to 65.6, 80.4, 95.9, and 65.9 mg/kg for

2,4,5-trichlorophenol , 4-bromo-2,5-dichlorophenol, 4-iodo-2,5dichlorophenol, and 3,5,6-trichloro-2-pyridinol, respectively.
The higher dose, 1.66 m moles/kg, is equivalent to 328, 401.9, and
329.5 mg/kg for 2,4,5-trichlorophenol, 4-bromo-2,5-dichlorophenol,
and 3,5,6-trichloro-2-pyridinol, respectively.
Gas Chromatographic Analysis of
Halogenated Phenols and a
Pyridinol in Tissues
The recovery of the study compounds in analysis of these tissues
was generally very acceptable except for the pyridinol in fat which
was 54 . 1%.

No interference peaks were present in the tissues analyzed;

however, some liver and kidney tissues analyzed for 2,4,5-TCP and the
pyridinol contained small peaks, just beyond the apex of the pyridinol
peak on the trailing edge, and for 2,4,5 - TCP coincident with the GC
peak.

This interference was not identified but it was believed to be

not due to pyridinol based upon data presented by lvey et al. (1978)
and lvey (1979).

In previous studies with Dursban in plants, it was
found that dehalogenation of the [CJ 36 ] 3,5,6-trichloro-2-pyridinol
could occur and [c1 36 ] chloride could be found in the tissues (Smith
et al. 1967). Smith et al. (1967) studied the metabolism of [c1 36 ]
chlorine-labeled chlorpyrifos in rats, chickens, and dogs and showed
that [c1 36 ] chlorine-labeled material was present in trace quantities
in the tissues which were eliminated from the body at a rate different
from that of the major compound chlorpyrifos being investigated.
They suggested that this minor compound might be present in the
original compound as an impurity, or the compound might be undergoing
enzymatic dehalogenation with the formation of radioactive chloride.
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Today, one must consider the probability that the "dehalogenated"
residu e observed by Smith et al. (1967) was actually 2,5,6 -TC-2pyridinol.

There are several possible benzene oxides which can be

der ived from i .p. administration of 300 mg 1,2,4-trichlorobenzene
to the male rabbit (Kohli et al. 1976), and one of these 2,4,5trichlorobenzene oxides is the most likely precursor for the metabolite 2,4,5-trichlorophenol.

The 2,4,5-trichlorobenzene oxide could

give the corresponding phenol by direct opening of the c2 o) bond
or by the NIH shift of chlorine. Also, it has been found that
2,4,5-TCP is metabolized to 3,5-dich loro-catecho l in soil and water
(Rosenberg and Alexander 1980).

These results indicate some possible

routes to compounds representing the unknown peaks of halogenated
phenols and pyridinol metabolites in animals.

Studies of these com-

pounds is needed in the future.
Twenty-Four Hour Concentrations
The halogenated phenols and pyridinol were differentially
distributed in every tissue sampled following the administration,
even though the total amount of halogenated phenols and pyridinol
administered was the same.

The difference could possible be due

to preferential absorption from the gastrointestinal tract or to
preferential elimination of certain compounds.

As the concent ra -

tion of the dose administered increased, the percent concentration
of the compounds in tissues tended to be lower and the elimination
from the tissues became slower.

The highest amounts of halogenated

pyridinol residues were observed in liver, then followed by kidney,
fat, and blood whereas the highest residues of halogenated phenols
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were observed in kidney, followed by liver, fat, and blood .

In

general, the 24 h concentration in fat and kidney tissues showed
2,4,5-TCP

<

4-Br-2,5-DCP

<

4-l-2,5-DCP > 3,5 ,6-TC-2-pyridi nol, where-

as the concentrations of these compounds in liver tissue gave the
inverse series.

The concentrations of these compounds in blood

were similar and not significantly different, however the halogenated
pyridinol concentration was higher t han that of the halogenated
phenols.

The average concentrations of these compounds, based on

either lipi d or tissue wei ght, follow the same order and the same
pattern as above.

The only difference found was that the concen-

trations of all compounds were higher on a lipid basis than that
found on a tissue basis in liver.
These findings are consistent with evidence from other animal
experiments which indicated that the 3,5,6-trich loro- 2- pyridinol
concentrates in liver more than kidney and fat such as when cattle
were fed chl orpyrifos daily for 30 days at 1eve 1s of 3 to 10 ppm
(Dishburger et al. 1977) and similar results obta ined with cattl e
bearing chlorpyrifos
1978).

impregnated plastic ear bands (Ivey et al.

Also, McKellar et al. (1972) found the residues of 3,5,6-

trichloro-2-pyridinol occurred predominantly in liver and kidney
of swine when the animals were fed chlorpyrifos in their diet for
30 days.

Similar results were obtained when chickens were fed

chlorpyrifos (D i shburger et al. 19 72).

This means that there must

be a very large turnover of halogenated pyridinol in the rat liver
since it has been reported that liver contains th e predomi nant

1
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concentration of halogenated pyridinol compared to the kidney and
the fat.

The increase of halogenated phenol residues in the kidney

is not surprising, however, since the kidney would be one of the
pathways for the elimination of halogenated phenols from the body.
It is known that rats primarily excrete phenols via the kidneys
(Goldstein et al . 1974) and that related halogenated phenols may
act similarly.

That is in agreement with the higher rate of

excretion of halogenated phenols in the urine as found by Bradway
et al. ( 1977) and Shafik et al. (1973) who found that the urinary
halogenated phenols and pyridinols excretion as metabolites of
rats exposed to Ronnel, Leptophos, Dursban, Bromophos, and C-9491
were complete within l-4 days.

However, when the rate of absorp-

tion exceeded the rate of excretion, the toxic compound accumulated
to a critical concentration in the body . Accumulation may also
occur if the compound is so lipid-soluble that it is reabosrbed
by the renal tubules after filtration (Goldstein et al. 1974).
The accumulation of the halogenated phenols and pyridinol studied
herein appear to be consistent with this concept.
Relationship of Lipophilicity and
Concentration of Halogenated Phenols
and Pyridinol in Tissues
Generally, the most important physio-chemical fac tor influencing
the ability of a foreign compound to achieve effective concentrations
in various biological phases is lipid solubility.

The lipid-protein

structure of cellular membranes requires that the foreign substance
have sufficient lipophilicity to partition into the membrane, largely
by diffusion, in order to cross into the cell.
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Various methods of evaluating relative solubility parameters
appear in the literature .

The Hansch approach to regression analysis

in structure-activity studies generally employs the relative octanolwater partition coefficient, known as n.
p

n = log(p X)
H

In this study the relative lipophilicity values, as measured
by Rm for halogenated phenols and pyridinol, were generally very
well correlated with the log residue concentration of compounds in
all tis sues as shown in Table 7 and Table 8.

The data presented in

Table 7 and in Table 8 are summarized in Figures 8 and 9 to illustrate the relationship between the lipophilicity, Rm, and the halogenated phenols and pyridinol concentrations in tissues 24 h after
dosing.

Increased concentration in tissue correlated with increased

lipophilicity, the Rm' for the cases of fat and kidney .
Tables 9 and 10 show data for halogenated phenols and pyridinol
and the results of regression analyses of compound concentrations
as a function of lipophilicity.

A strong linear correlation was

seen for all compounds in fat, kidney, and liver at both dose levels.
The compounds had a poorer correlation in the case of blood (at
lower dose only).

It is possible that the residue concentration in

blood peaked much earlier than 24 h and that the measurements made
here at 24 h, were at a time well into the process of redistribution
from blood to tissues.

Measurements made at shorter time intervals

might well haveshownastrongcorrelation of blood residues

with~ ·
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Figure 8. Effect of lipophilicity of halogenated phenols and
pyridinol on concentration in tissues 24 h after administration
of 0.33 m moles/kg. Solid circles (e) represent ng/g lip i d and
the open circles (o) represent ng/g tiss ue.
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Fi gure 9. Effect of l ipophilici ty of halogenated phenols ~n d pyridinol concentration in tiss ues 24 h afte r administrati on of 1. 66 m
moles / kg. So lid c ircles (e ) represent ng/g li pi d and the open
circles (o ) represent ng/g tissue.

Table 7.

Concentrations of Halogenated Phenols and Pyridinol in Tissues 24 h After Administration
(0.33 m moles/kg) and their Chromatographic Rm Values

La
Compound

Rm

c

Bl ooda

Fat b

Kidney
Lipi dot
T i ssuec

Liver
Ti ssuec

Lipi dd

2,4,5-trichlorophenol

+0 .035

3.32

2.39

2.54

4 . 16

1.67

3.03

4-bromo-2,5- dichlorophenol

-0.045

3. 29

2.15

2.48

4.17

2.01

3. 72

4-Iodo-2,5-dichlorophenol

-0 .2 31

3 .41

2.17

1. 76

3 .82'

2.1 1

3.81

3,5,6-trichloro-2pyridinol

-0.908

3.37

1.19

l.E7

3 . 04

2.66

4 . 26

alog concentration pg/g tissue.
blog concentration ng/g extractable fat.
clog concentration ng/g tissue.
dlog concentt·ation ng/g lipid s.

':."!

Table 8.

Concentrations of Halogenated Phenols and Pyridinol in Tissues 24 h After Administration
(1.66 m moles/kg) and their Chromatographic Rm Values
Log Concentration

Compound

Rm

Bl ooda

Fatb

Kidnel
Lipidd
Ti ss uec

Liver
Ti ssuec
Lipidd

2,4,5-trichlorophenol
4-bromo-2 ,5-dich 1oropheno 1
3,5,6-trichloro-2pyridinol

+0 .035

4.23

2.84

2. 71

4.42

l. 95

3.63

-0 .045

4.23

2.47

2.79

4.44

2.48

4.17

-0.908

4.24

2.40

2.40

4.05

3.36

5.04

aLog
blog
clog
dLog

concentration
concentration
concentration
concentration

pg/g
ng/g
ng/g
ng/g

tissue.
extractable fat .
tissue.
lipid.

"'
N

Table 9.

Correlation of the Halogenated Phenols and Pyridino l Concentrations in Tissue with Rm 24 h After
Administration of 0.33 m moles/kg

s)a

Tissues

Regression equat ion

(n

r

Blood

Log Cb = 3.331 - 0.064 Rm

4

-0.517

.120

Fat

Loa cc = 2.328 + 1.227 Rm

4

0.982

.239

Kidney

Loq cd = 2.363 + 0.879 R
Loq Ce = 4.150 + 1.235 R~

4
4

0 .813
0. 995'

.222
.240

Log cd = 1. 845 - .924 R
Log ce = 3.543 - 0.822 ~m

4
4

-0.961
-0 .926

. 210
. 202

Liver

an is the nunber of halo~ena ted ~henols and pyridinol in the re~:Jress ion .
r is the correlation coefficient, and
s is the standard error of the estimate .
blog
clog
dlog
elog

concentration
concentration
concentration
concentration

pg/g
ng/g
ng/g
ng/g

tissue.
extractable fat.
tissue.
lipid .
w
"'

Table 10.

Correlation of Halogenated Phenols and Pyridinol Concentrations in Tissue with Rm 24 h After
Administration of 1.66 m mo l es/kg
s )a

Ti ssues

Regress i on Equation

Blood

Log cb

=

4.228 - 0. 015 ~

- . 965

. 153

Fat

Log cc

=

2.663

.681

.203

Kidney

Log Cd
Log Ce

=
=

2.751 + .377 Rm
4.430 + .416 Rm

. 964
.993

.2 10
.214

Liver

Log cd
Log Ce

=
=

2. 197 - 1.306 !!m
3. 883 - 1 . 299 Rm

-.955
-.952

. 357
.357

an
r

s
blog
clog
dlog
elog

+

(n

3.065 Rm
3
3

the nu~ber of halo9enated phenols and pyridi nol in the regr es sion.
the corre l ation coeffi cient, and
the standard error of the estimate
concentration
concentration
concentration
concentration

pg/g
ng/g
ng/g
ng/ g

tissue.
extractab l e fat.
tiss ue.
lipid.

"'_,.
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This was consistent with the concept that compounds must have
lipophilicity to cross membranes, but there were some exceptions
as indicated in blood and liver tissue concentration which shows
the concentration was inverse to the increase of the lipophilicity
of the compounds.
This provided one of the most important exceptions to the
generalization that increasing lipid solubility enhances concentration.

The reason for that exception in the liver is not known

at the present time.

However, there may be binding of this com-

pound with biological macromo lecul es in this organ.

This would

argue from the report that trichlorophe nol and the pyridinol reduced
thyroxine (T 4 ) bound to liver mitochondria by 10 to 30% (Beck 1976).
Also, it was indicated that the trichlorophenols, the dichlorobromo-phenol and the pyridinol bind at least as well as T4 (itself)
to the T4-binding site of bovine serum albumin in vitro. The relative binding affinity was found higher for the halogenated pyridinol
than t hat found for 2,4,5-trichloropheno l.

So protein and/or

organele binding may be a reason for the concentration increase in
blood and liver and the delayed clearance from liver.
Often drugs are conjugated in liver first, and then pass into
bile as a glucuronide, sulfate, glycinate or gluthione conjugate,
and pass into the intestine.

If the properties of the drug happen

to be favorable for intestinal absorption, a cycle may result
(enterohepatic cycle) in which biliary excretion and intestinal
reabsorption continue until renal excretion finally eliminates the
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drug from the body (Goldstein et al. 1974).

It was found that sheep

plasma contained the glucuronide of 3,5,6-trichloro-2- pyridinol as
well as urine when the sheep were given a single oral dose of
chlorpyrifosmethyl or its metabolite 3,5,6-trichloro-2-pyridinol
(Bakke and Price 1976).

That means the glucuronide pyridinol was

reabsorbed from the intestine and recycled causing the little elevation in its blood concentration which was found.

The other possi-

bility is that conjugation with glucuronic acid probably takes place
in the gastrointestinal tissues prior to the phenol's absorption
into the blood (Pekas and Paulson 1970).

Bakke and Price (1976)

reported that 3,5,6-TC-2-pyridinol was absorbed rapidly into the
blood of the sheep and excreted rapidly in urine .
Any other reason for the higher concentration of 3,5,6-TC-2pyridinol in liver may be related to the electronegativity of nitrogen that makes pyridine unreactive toward electrophilic substitution
but makes pyridine highly reactive toward nucleophilic substitution.
As is well known, some conjugation reactions occur through nucleophilic attack by the electron rich atom .

Thus, 3,5,6- TC - 2-pyridinol

conjugation with glucuronide occurs very rapidly as reported by
Bakke and Price (1976).
Depletion of Halogenated Phenols
and Pyridinol in Tissues
The levels of ha logenated phenols and the halogenated pyridinol
in tiss ue decline with time, however, the rates of decline were different for different t issues and for different compounds used.

This

kinetic study of hal oge nated phenols and pyridino l indicated a
persistence of compounds in various tissue after an initial rapid
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dec line with time, but not always in an apparently log linear fashion .
An ini tia l rapid decline phase followed by a slower decline was shown
i n most tissues.

The decline of 3,5,6-TC -2-pyridinol in liver and

2,4,5-TCP in kidney were exceptions which showed very slow decline
and persistence of significant residues to the twelfth day.
The reason for persistence of 2,4,5-TCP in kidney and 3,5,6TC-2-pyridinol in liver may be binding of these compounds with
biological macromolecules.

Pyridinol association with the liver

mitochondrial fraction may be a factor also, in analogy to the
specific binding of T4 and T3 ( Krenni·ng et al. 1980).
The levels of halogenated phenols and pyridinol in blood
declined rapid ly when compared to most other tissues as suggested
by the comparative levels of these compounds at various time periods
following administration of a single oral dose of the compound .

This

may indicate continued partitioning fnto tissues showing slow kinetics
such as kidney and liver, bec?use it is seen that the rats have
ability to rapidly detoxify and eliminate phenols from the blood
(Go ldstein et al . 1974) . Although halogenated phenols and pyridinol
were not analyzed separately in plasma and blood cells, earlier
studies have indicated that most of the pyridinol in blood is found
in the plasma (Bakke et al. 1976).
The rates of decline from fat were slower than those found in
the blood with time and the persistence of all compounds in fat
with time exceeded that found in blood.
The concentrations of compounds in the lip i d fraction of each
tissue were not identical.

These differences may be due to factors
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such as the structure of lipid in each tissue, the permeability of
tissue vascular systems to compounds and solubility of the compounds which related to the lipophilicity in this study.

The

compounds may thus display some special affinity for some specific
component of lipid such as has been shown for DDT (Tinsely et al.
1971).
The results indicated that there may be possible quantitative
differences in the kinetics of halogenated phenols and pyridinol
distribution of different dose l evels .

The relative tissue concen-

tration of compounds as reflected by tissue:blood ratios were consistently increased with time after admin i stration.

The accumula-

tion of compounds in tissues appears to be a direct function of the
dose administered but

~oth

the dose levels used in this

s~udy

were

not in a linear relationship because the lower dose level of compounds produced a significantly greater concentration in tissues
than the higher dose level in rela t ion to the percent dose administered; however, it is possibly only at t he lowe r dos e levels that
a linear relationship may be expected.
If further studies are to be carried out in t his area, there
are some points that should be implemented.

Samples of tissues

should be collected between 1 and 24 h in addition t o the samp le
times used in this study to investigate the exact time of peak
uptake in tissues .

Due to the l ipophilicity of thes e compounds,

they are expected to distribute to most tissues, hen ce other critical
tissues should be sampled, especiall y brain, bile , muscle, and
gastrointestinal tract and contents.

Bakke et al . (1976) reported
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that sheep bile, liver, kidney, and gastroin t estinal tract with its
contents contained detectable residues of 3,5,6-trichloro-2-pyridinol
after a single oral dose of chlorpyri fos or 3,5,6-trichloro-2pyridinol and that other related hal ogenated phenols may act
similarly.

Also, urine and feces should be sampled to know the

fate of all compounds in the body of the animal . because the rates
of halogenated phenols and pyridinol s removal from tissues are
expected to be reflected in their ra t es of excretion.

It would be

instructive to determine the halogenated phenols and pyridinols
in tissues in future work following s pecific organophosphorus
pesticides administration to animals for metabolism studies,
because halogenated phenols are the major metabolites of these
pesticides.

Finally, although there were no indications of halo-

genated phenols and pyridinols metabolites, such as the partial
dechlorination or the shift of chlorine which could occur (Smith
et al. 1967 and Kohli et al. 1976), s t udies designed differently
might produce evidence of such compounds as metabolites .
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SUMMARY
This thesis was initiated to determine the structur e-activity
relationships among halogenated phenols and a pyri dinol in terms
of their distribution and accumulation in selected

ti s s ~ es

and the

kinetics of their decline from those tissues . The compounds used
in the studies were 2,4,5-trichlorophenol , 4-bromo- 2,5 -dichlorophenol , 4-iodo-2,5-dichlorophenol, and 3,5, 6-trichloro-2-pyridinol.
There was no evidence whatsoever of advers e effects at t he dose
levels employed.
The compounds were chromatographed in revers ed-phas e thin
layer chromatography as a measure of their rela t i we l i pophilicity
values (Rm).

The

~values

were found to be gener all y very well

correlated with the log concentration of these compounds in tissues.
The correlation coefficients were - .51 7, .982, .813, and - . 961 for
the low dose level of these compounds in bl ood, f• t , kidney, and
liver based on the tissue weight, respectivel y.
cients of .995 and -.926 were calculated fo r
on the lipid content.

Cor rel ation coeffi-

kid n ~y

and liver based

Similar correlation coeffi c i ent s were -.965,

.681, .964, and -.955 for the high dose level of t hese compounds in
blood, fat, kidney, and liver based on the ti ssue wei ght , respectively,
or .993 and - .952 in kidney and liver based on

t h~

l ipid content,

respectively.
The levels of compounds in tissues decli ned w·i t h t ime, however,
the rates of decline were different for diffe rent tissues and for
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different compounds .

All compounds appear to be redistributed from

blood and perhaps other tissues, thus fat and liver decline rates
become slow relative to blood.
The persistence of the compounds in tissues after an initial
rapid decline with time indicated quantitative differences in the
kinetics of compounds distribution at different dose levels .
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Appendix A

Table 11 .

Mean Body Weight {g±S.E.a) of Rats at Various Time Periods After a Single Oral Dose of
Halogenated Phenol or Pyridinol
Days

Treatment
2, 4,5-trichlorophenol
0.33 1'1 moles/kg
1.66 m moles/kg

.

0

1

3

6

12

182 ± 4 (8)b
186 ± 3 (8)

188 ± 4 (8)
190 ± 4 (8)

211±5 (6)
210 ± 5(6)

230 ± 5 (4)
241 ± 5 (4)

276 ± 8 (2)
271 ± 8 (2)

185 ± 3 (8)
185 ± 3 {8)

190 ± 3 (8)
190 ± 3 {8)

209 ± 4 (6)
218 ± 3 (6)

238 ± 7 (4)
250 ± 4 (4)

248 ± 1 (2)
288 ± 4 (2)

186 ± 3 (8)

190 ± 3 (8)

210 ± 5 (6)

232 ± 8 {4)

266 ± 2 {2)

183 ± 3 ( 8)
186 ± 2 (8)

186 ±3 {8)
185 ± 3 (8)

209 ± 4 (6)
210 ± 4 ( 6)

240 ± 6 (4)
232 ± 12 (4)

280 ± 2 (2)
274 ± 7 (2)

185 ± 2 (8)

190

207 ± 3 (8)

232 ± 4 (8)

265 ± 5 (8)

4-bromo-2,5-dichlorophenol
0.33 m mole s/kg
1.66 m moles/kg
4-iodo-2,5-di chl orophe nol
0.33 m moles/kg
3,5,6-trichloro-2-pyridinol
0.33 m mol es/kg
1.66 m moles/kg
Control

±

aStandard error of the mean .
bValue in parentheses is the number of animals .

2 (8)

00
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Table 12.

Mean Relative Kidney and Liver Weight (g tissue/100 g body weight ± S.E.a) of Rats at Various
Time Periods After a Single Oral Administration of Halogenated Phenol or Pyridinol
Days

Treatment
2,4 ,5-tri chlorophenol
0.33 m moles/kg
0.33 m moles/kg
1.66 m moles/kg
1.66 m moles/kg

Ti ss ue

1

3

6

12

Kidney
Liver
Kidney
Liver

0.81 ± .01
4.34 ± .02
0.85 ± .01
4.75 ± .51

0.91 ± .04
4.11 ± .08
0.79 ± .03
4.35 ± .16

0.80 ± .02
3. 72 ± . 05
0.84 ± .04
4.07 ± . 15

0.77 ± .05
3. 63 ± . 17
0.78 ± .03
3.86 ± .09

4 ,bromo-2, 5-di chl oropheno 1
0.33 m moles/kg
0.33 m moles/kg
1.66 m mo le s/kg
1.66 m moles/kg

Kidney
Liver
Kidney
Liver

0.81
4.08
0 .85
4.21

.03
.25
.02
.08

0 .89 ± .02
4.00 ± . 14
0.84 ± .04
4. 27 ± .14

0.82 ± .01
3. 57 ± . 44
0.79 ± .02
3.84±.13

0 .80 ±
3.44±
0.81 ±
3.89 ±

4-iodo-2,5-di chlorop henol
0.33 m moles/kg
0.33 m moles/kg

Kidney
Liver

0.81 ± .09
4.27 ± .18

0 . 81 ± .04
4.18 ± .01

0.79 ± .04
3.69 ± .08

0.75 ± .03
3.82 ± . 18

3,5,6-trichloro-2-pyridinol
0.33 m mol es/kg
0.33 m mole s/kg
1.66 m moles/kg
1.66 moles/kg

Kidney
Liver
Kidney
Liver

0.82 ± .03
4.37 ± .00
0.85 ± .04
4.20 ± . 18

0 .89 ± .02
3.98 ± .01
0.84 ± .02
4 . 15 ± .06

0.84 ± .02
3.73 ± .29
0.80 ± .02
3.45 ± .00

0.80 ± .03
4.02 ± .01
0.83 ± .08
3. 99 ± . 17

Kidney
Liver

0.81 ± .06
4. 43 ± .20

0.78 ± .02
3.96 ± .08

0.83 ± .01
3.58 ± .01

0.78 ± .01
3. 56 ± .09

Control

±
±
±
±

.04
.1 9
.03
.02

co

aStandard error of the mean; each value represents an average of two animals.
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Table 13.

Distribution of Halogenated Phenols and Pyridinol in Rats Organs Following Oral
Administration

Days After Dosing
Treatment

Organs a

l

3

6

12

2, 4, 5-trich l oropheno l
0.33 m moles/kg

Bloodb
Fatb

1.66 m moles/kg

. 030 (. 0003)

.032 ( .0003)

3.135 ( .030)

2. 144 ( .019)

NDc

NO

. 498 ( .005)

.384 ( . 004)
.018 ( .000 2)

Kidney

.498 (.005)

.277 ( .003 )

.247 (.002)

Liver

.360 (.003)

.344 (.003)

.043 ( .004)

Bloodb

.262 ( .0004)

.058 (.0001)

.019 ( .00003)

.016 ( . 00003)

Fatb

ND

11.442 (.019)

4. 115 ( . 007)

.695 ( .001)

.352 ( .001)

Kidney

.861 ( .005)

.457 (.001)

.573 ( . 001)

. 028 (. 0001)

Liver

. 826 (. 001)

.395 (.001)

.060 (.0001)

. 037 ( . 0001 )

Bloodb

. 029 (. 0002)

.003 (.00002)

4-bromo-2,5-dichlorophenol
0.33 m moles/kg

Fatb

1.66 m moles/kg

1.878 (.015)

NO

.515 ( .004)

. 187 ( .001)
.010 (.0001)

NO
. 125 (.001)
NO

Kidney

.465 (.004)

. 035 (. 0003)

Liver

. 783 (. 006)

.027 (.0002)

Bl oodb

. 235 ( .0004)

.003 ( .0004)

.007 ( .00001)

ND

Fatb
Kidney
Liver

ND

NO

.6 13 (.001)

.358 (.0005)

.28 7 ( .0004)

.931 ( .001)

. 140 ( . 0002)

.071 (.0001)

ND

2.254 (.003)

. 320 ( . 0004)

. 162 ( . 0002)

NO

4.566 ( .007)

00
..._,

Table 13. (Continued)

Days After Do si ng
Treatment

Organs a

1

3

6

12

ND

ND

4- i odo-2, 5-di ch 1orophenol
0.33 m moles/kg

Bloodb
Fatb
Kidn ey
Liver

.038 ( .0002)
1.903 {.012)

.002 (.00001)
. 236 (. 002)

. 078 ( . 0005)

ND

. 087 ( .001)

. 051' ( . 0003)

.005 (.0000 3 )

ND

1. 026 (. 007)

.031 ( .0002)

,013 (.0001)

ND

3,5,6-trichloro-2-pyridinol
0 .33 m moles/kg

81 oodb

. 034 (. 0003)

.002 ( . 00002)

Fatb

.266 ( .002)

. 102 ( .001)

. 083 ( .001)

Kidney

. 069 ( . 001)

. 014 ( .0001)

.009 (. 0001)

.662 ( . 006}

.333 (.003)

Liver
1 . 66 m mo 1 es/ kg

Bloodb
Fatb
Kidney
Liver

3 .617 (.033)

ND

ND
ND
ND
.263 (.0002)

.019 ( .00003)

.017 (.00003)

NO

5.007 (.009}

. 211 ( . 0004)

. 168 ( .0003)

NO

.396 (.001)

.121 (.0002)

.013 (.00002)

. 251 (. 0004)

17. 839 ( .031)

3 . 146 (.005)

2.157 {.004)

ND
2 . 609 ( . 004)

aEach value represents the content (ug) of chemical in the whole organ, average of two animals; value
in parentheses is percentage of the original dose.
0 99
bEstimated organ wei9h/i was calculated (Lindstrom et al. 1974) as blood [B ( ) = 77 (B.ILk ) · ] and
fat [Fm(g) = 180 (B . W.kg) · ].
m9
9
eND, not detected .

00
00
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Table 14.

Concentration of Halogenated Phenols and Pyridinol in Tissue After Administrationa

Treatment

Days

Bloodb

Fat
Ti ssueb

2,4,5- trichlorophenol
0.33 m moles/kg

1. 66 m moles/kg

4- bromo-2,5-dich1oropheno1
0.33 m moles/kg

1. 66 m moles/kg

1
3
6
12
1
3
6
12
1
3
6
12
1
3
6
12

Ti ssues Concentration
Kidney
Lipide
Tissue b Li pi dd

Liver
Ti ssueb

Lipidd

ND
17.0
3. 7
1.0
.8

97.3
54.6
11.9
ND
328 .0
114 .4
15 .6
7.3

247.1
111 .4
24 .0
7.4
688.0
19 2.7
34 .8
14.9

345.6
139.0
134.5
8.6
515 . 7
289 . 4
275 .5
13.1

14 . 5
8. 0
8.0
.5
26.3
17.1
16 .8
0.8

46 . 4
38.3
5. 0
ND
88.8
45.4
5.9
3.5

2.1
1.7
0.2
ND
4.2
1. 8
.3
.2

1.9
0.2
NO
ND
16.9
0.3
0. 4
ND

55.3
15.1
4.3
1.4
142.7
15.5
8 .0
5.5

141.9
26.4
8.0
2. 1
292.6
29.2
19.0
9.3

303.7
19.3
5.3
ND
616.2
77.0
36.3
ND

14.8
10.1
3.1
ND
27.5
10.3
4.0
ND

101.9
3.3
ND
ND
300.9
34.5
17.0
ND

5.3
0. 1
ND
ND
14 .8
1. 8
1.0
0. 3

2. 1
1.9

rl r

0
"'

Table 14.

(Continued)

Treatment

4-iodo-2,5-dichlorophenol
0.33 m moles/kg

3,5,6-trichloro-2-pyridinol
0.33 m moles/kg

1.66 m moles/kg

Days

Bloodb

---

Fat

Tissues Concentration
Kidney

Ti ssueb

Lipide

Tissueb

Lipidd

Liver
Tissueb

Lipidd

1
3
6
12

2.6
0.1
ND
ND

56.4
6.0
1.6
ND

148.1
12.5
2.6
ND

47.0
29.2
2.9
ND

6. 5
1. 3
0. 1
ND

128.2
3. 4
1.5
0.8

6.4
0.2
0.1
0.1

1
3
6
12
1
3
6
12

2.4
0.1
ND
ND
17.4
1.1
1.0
ND

8.2
2. 3
1.9
ND
117.3
5.5
4.4
ND

15.5
6. 7
4.8
4. 1
253.2
21.4
12.1
4.6

46.3
8.0
4.6
ND
253.2
67.1
7.6
ND

1.1
0. 4
0.1
ND
11. 2
4.3
0.2
ND

456.7
82 . 0
37 . 6
23.4
2313.7
355.1
212 . 6
238 . 7

18.0
3.9
1.5
1.0
110 . 7
16.3
13.0
11. 2

aEach value represents an average of two animals.
bConcentration ng/g tissue.
cConcentration ng/g extractable fat .
dConcentration ~g/g lipid.
ND = not detected.
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